comparemela.com
Home
Live Updates
Gilead Earnings Meet Expectations as It Seeks Recovery From Cancer Drug Stumble : comparemela.com
Gilead Earnings Meet Expectations as It Seeks Recovery From Cancer Drug Stumble
Gilead shares have slid 11.3% since the biotech reported disappointing lung cancer drug trial data on Jan. 22.
Related Keywords
David Paul Morris Bloomberg ,
Josh Nathan Kazis ,
Gilead Sciences ,
Biotech Gilead ,
Foster City ,
David Paul ,
Wall Street ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Cancer Drugs ,
Healthcare Life Sciences ,
Biopharmaceuticals ,
Specialized Drugs Medications ,
Financial Performance ,
Earnings ,
Sales Figures ,
Share Price Movement Disruptions ,
New Products Services ,
Research Development ,
Corporate Industrial News ,
Products Services ,
New Product Service Testing ,
Cancer ,
Political General News ,
Health ,
Medical Conditions ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Earnings Report ,
Biotech And Pharma ,
Gild ,
Share Price Movement ,
Disruptions ,
New Products ,
Services ,
Research ,
Development ,
Corporate ,
Industrial News ,
Products ,
New Product ,
Service Testing ,
Political ,
General News ,
Healthcare ,
Life Sciences ,
Specialized Drugs ,
Medications ,
comparemela.com © 2020. All Rights Reserved.